Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3421-3426

  Tong, Xiaowen ^a,c   Shine, David H ^a   Agoulnik, Irina ^a   Freund, Christian T F ^b   Hasenburg, Annette ^a   Aguilar Cordova, Estuardo ^a   Woo, Savio L C ^a   Kieback, Dirk G ^a,c  

^a Dept of Obstetrics and Gynecology ^*  (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Antagonism; Chemotherapy; Gene therapy; MTT assay; Ovarian cancer; Synergistic interaction

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; MITOXANTRONE; PACLITAXEL; THYMIDINE KINASE; TOPOTECAN;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; GENE THERAPY; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

ADENOVIRIDAE; ANTINEOPLASTIC AGENTS; AVIAN SARCOMA VIRUSES; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; FEMALE; GENE THERAPY; HUMANS; OVARIAN NEOPLASMS; THYMIDINE KINASE; TOPOTECAN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031730806     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE and Look KY: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334: 1-6, 1996.
2. Tong XW, Block A, Chen SH, Woo SLC and Kieback DG: Adenovirus-mediated gene therapy of human epithelial ovarian cancer by transduction with the thymidine kinase gene and exposure to ganciclovir. Anticancer Res 16: 1611-1618, 1996.
3. Tong XW, Block A, Chen SH, Contant C, Agoulnik I, Blankenburg K, Kaufman RH, Woo SLC and Kieback DG: In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration. Gynecol Oncol 61: 175-179, 1996.
4. Tong XW, Agoulnik I, Blankenburg KP, Contant CF, Hasenburg A, Runnebaum IB, Stickeler E, Kaplan AL, Woo SLC and Kieback DG: Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy. Anticancer Res 17(2A): 811-813, 1997.
5. Carmichael J, Degraff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
6. Denizot F and Lang R: Rapid colorimetric assay for cell growth and survival modifications to the ttetrazolium dye procedure giving improved sensitivity and reliability. Immunol Methods 89: 271-277, 1986.
7. Boothman DA, Trask DK and Pardee AB: Inhibition of potentially lethal DNA damage repair in human tumor cells by B-lapachone, an activator of topoisomerasde 1. Cancer Res 49: 605-612, 1989.
8. Potmesil M: Camptothecins, From bench research to hospital wards. Cancer Res 54: 1431-1439, 1994.
9. Hsiang YH, Hertzberg R and Hecht S: Camptothecin induces protein-linked DNA breaks vla mammalian topoisomerase I. J Biol Chem 260: 14873-14878, 1985.
10. Mattern MR, Hofmann GA, Mccabe FL and Johnson RK. Synergistic cell killing by ionizing radiation and topoisomerase inhibitor topotecan. Cancer Res 51: 5813-5816, 1991.
11. Kotoh S, Naito S, Yokomizo A, Kumazawa J, Asakuno K and Kohno K: Increased expression of DNA topoisomerase 1 gene and collateral sensitivity to camptothecin in human cisplatin- resistant bladder cancer cells. Cancer Res 54: 3248-3252, 1994.
12. Pratesi G, Tortoreto M, Corti C, Giardini R and Zunino F. Successful local regional therapy with topotecan of intraperitoneally growing human ovarian carcinoma xenografts. Br J Cancer 71: 525-528, 1995.
13. Marchesini R, Colombo A, Caserini C, Perego P, Supino R and Capranico G: Interaction of ionizing radiation with topotecan in two human tumor cell lines. Int J Cancer 66: 342-346, 1996.
14. Cheng YC, Grill SP, Dutschman GE, Nakayama K and Bastow KF. Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes simplex virus compound, in herpes simplex vurus-infected cells. J Biol Chem 258: 12460-12464, 1983.